Several epidemiological studies report a negative association between Cancer and Alzheimer’s disease (AD).
Objective:
To characterize the trajectories of memory loss in individuals with early amnestic cognitive impairment with and without history of previous cancer.
Methods:
Cognitive deterioration was assessed using the Montreal Cognitive Assessment (MoCA) or MoCA-Memory Index Score (MoCA-MIS) biannually in subjects with early amnestic cognitive impairment followed-up retrospectively from 2007 to 2021. History of Cancer was obtained from clinical records. Simple linear regressions of MoCA-MIS scores were calculated for each subject and analyzed with K-means cluster analysis to identify subgroups with different cognitive decline trajectories. χ2 and t tests were used for descriptive categorical and continuous variables and mixed multiple linear regressions to determine cognitive decline covariates.
Results:
Analysis of the trajectory of cognitive decline in 141 subjects with early amnestic cognitive impairment identified two subgroups: Fast (n = 60) and Slow (n = 81) progressors. At baseline Fast progressors had better MoCA-MIS (p < 0.001) and functionality (CDR p = 0.02, AD8 p = 0.05), took less anti-dementia medications (p = 0.005), and had higher depression rates (p = 0.02). Interestingly, Fast progressors slowed their speed of memory decline (from 1.6 to 1.1 MoCA-MIS points/year) and global cognitive decline (from 2.0 to 1.4 total MoCA points/year) when Cancer history was present.
Conclusion:
Two trajectories of amnestic cognitive decline were identified, possibly derived from different neurophysiopathologies or clinical stages. This study suggests that a history of previous Cancer slows down amnestic cognitive decline, specifically in a subgroup of subjects with depression at baseline and accelerated deterioration at follow-up.
CromeL (1963) Mental Illness and the Ageing Brain. By J. A. Corsellis. Oxford University Press. 1962. Pp. viii+76. Price 30 s. Br J Psychiatry 109, 322–323.
2.
DeSoukyAL (1992) The relationship between cancer and Alzheimer’s disease. J Am Geriatr Soc40, 1075.
3.
YamadaM, SasakiH, MimoriY, KasagiF, SudohS, IkedaJ, HosodaY, NakamuraS, KodamaK (1999) Prevalence and risks of dementia in the Japanese population: RERF’s Adult Health Study Hiroshima Subjects. J Am Geriatr Soc47, 189–195.
RoeCM, FitzpatrickAL, XiongC, SiehW, KullerL, MillerJP, WilliamsMM, KopanR, BehrensMI, MorrisJC (2010) Cancer linked to Alzheimer disease but not vascular dementia. Neurology74, 106–112.
6.
AttnerB, LithmanT, NoreenD, OlssonH (2010) Low cancer rates among patients with dementia in a population-based register study in Sweden. Dement Geriatr Cogn Disord30, 39–42.
7.
RealmutoS, CinturinoA, ArnaoV, MazzolaMA, CupidiC, AridonP, RagoneseP, SavettieriG, D’AmelioM (2012) Tumor diagnosis preceding Alzheimer’s disease onset: Is there a link between cancer and Alzheimer’s disease?J Alzheimers Dis31, 177–182.
8.
DriverJA, BeiserA, AuR, KregerBE, SplanskyGL, KurthT, KielDP, LuKP, SeshadriS, WolfPA (2012) Inverse association between cancer and Alzheimer’s disease: Results from the Framingham Heart Study. BMJ344, e1442.
9.
MusiccoM, AdorniF, di SantoS, PrinelliF, PettenatiC, CaltagironeC, PalmerK, RussoA (2013) Inverse occurrence of cancer and Alzheimer disease: A population-based incidence study. Neurology81, 322–328.
10.
NudelmanKNH, RisacherSL, WestJD, McDonaldBC, GaoS, SaykinAJ (2014) Association of cancer history with Alzheimer’s disease onset and structural brain changes. Front Physiol5, 423.
11.
Benito-LeonJ, RomeroJP, LouisED, Bermejo-ParejaF (2014) Faster cognitive decline in elders without dementia and decreased risk of cancer mortality: NEDICES Study. Neurology82, 1441–1448.
12.
FrainL, SwansonD, ChoK, GagnonD, LuKP, BetenskyRA, DriverJ (2017) Association of cancer and Alzheimer’s disease risk in a national cohort of veterans. Alzheimers Dement13, 1364–1370.
13.
Sánchez-ValleJ, TejeroH, IbáñezK, PorteroJL, KrallingerM, Al-ShahrourF, Tabarés-SeisdedosR, BaudotA, ValenciaA (2017) A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer’s disease, glioblastoma and lung cancer. Sci Rep7, 4474.
14.
SeddighiS, HouckAL, RoweJB, PharoahPDP (2019) Evidence of a causal association between cancer and Alzheimer’s disease: A Mendelian randomization analysis. Sci Rep9, 13548.
15.
GuptaA, PreisSR, BeiserAS, SplanskyGL, DeCarliCS, AuR, DriverJA (2019) Relationship of cancer to brain aging markers of Alzheimer’s disease: The Framingham Heart Study. Adv Geriatr Med Res1, e190006.
16.
SunM, WangY, SundquistJ, SundquistK, JiJ (2020) The association between cancer and dementia: A national cohort study in Sweden. Front Oncol10, 73.
17.
MaL-L, YuJ-T, WangH-F, MengX-F, TanC-C, WangC, TanL (2014) Association between cancer and Alzheimer’s disease: Systematic review and meta-analysis. J Alzheimers Dis42, 565–573.
18.
ZhangQ, GuoS, ZhangX, TangS, ShaoW, HanX, WangL, DuY (2015) Inverse relationship between cancer and Alzheimer’s disease: A systemic review meta-analysis. Neurol Sci36, 1987–1994.
19.
Catalá-LópezF, Suárez-PinillaM, Suárez-PinillaP, ValderasJM, Gómez-BeneytoM, MartinezS, Balanzá-MartínezV, ClimentJ, ValenciaA, McGrathJ, Crespo-FacorroB, Sanchez-MorenoJ, VietaE, Tabarés-SeisdedosR (2014) Inverse and direct cancer comorbidity in people with central nervous system disorders: A meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosomatics83, 89–105.
20.
Ospina-RomeroM, GlymourMM, Hayes-LarsonE, MayedaER, GraffRE, BrenowitzWD, AckleySF, WitteJS, KobayashiLC (2020) Association between Alzheimer disease and cancer with evaluation of study biases. JAMA Network Open3, e2025515.
21.
FreedmanDM, WuJ, ChenH, KunclRW, EnewoldLR, EngelsEA, FreedmanND, PfeifferRM (2016) Associations between cancer and Alzheimer’s disease in a U.S. Medicare population. Cancer Med5, 2965–2976.
22.
HansonHA, HornKP, RasmussenKM, HoffmanJM, SmithKR (2016) Is cancer protective for subsequent Alzheimer’s disease risk? Evidence from the Utah Population Database. J Gerontol B Psychol Sci Soc Sci72, 1032–1043.
23.
RoderburgC, LoosenSH, KunsteinA, MohrR, JördensMS, LueddeM, KostevK, LueddeT (2021) Cancer patients have an increased incidence of dementia: A retrospective cohort study of 185,736 outpatients in Germany. Cancers (Basel)13, 2027.
24.
Tabarés-SeisdedosR, RubensteinJL (2013) Inverse cancer comorbidity: A serendipitous opportunity to gain insight into CNS disorders. Nat Rev Neurosci14, 293–304.
25.
DriverJA, ZhouXZ, LuKP (2015) Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer’s disease. Biochim Biophys Acta1850, 2069–2076.
26.
NudelmanKNH, McDonaldBC, LahiriDK, SaykinAJ (2019) Biological hallmarks of cancer in Alzheimer’s disease. Mol Neurobiol56, 7173–7187.
27.
BehrensM, LendonC, RoeC (2009) A common biological mechanism in cancer and Alzheimer’s disease?Curr Alzheimer Res6, 196–204.
28.
Forés-MartosJ, BoullosaC, Rodrigo-DomínguezD, Sánchez-ValleJ, Suay-GarcíaB, ClimentJ, FalcóA, ValenciaA, Puig-ButilléJA, PuigS, Tabarés-SeisdedosR (2021) Transcriptomic and genetic associations between Alzheimer’s disease, Parkinson’s disease, and cancer. Cancers (Basel)13, 2990.
van der WillikKD, SchagenSB, IkramMA (2018) Cancer and dementia: Two sides of the same coin?eEur J Clin Invest48, 13019.
31.
van der WillikKD, SchagenSB, IkramMA (2020) Association between the tumor marker carcinoembryonic antigen and the risk of dementia. J Alzheimers Dis76, 845–851.
32.
Ospina-RomeroM, AbdiwahabE, KobayashiL, FilshteinT, BrenowitzWD, MayedaER, GlymourMM (2019) Rate of memory change before and after cancer diagnosis. JAMA Network Open2, e196160.
33.
BernickC, CummingsJ, RamanR, SunX, AisenP (2012) Age and rate of cognitive decline in Alzheimer disease: Implications for clinical trials. Arch Neurol69, 901–905.
34.
StanleyK, WhitfieldT, KuchenbaeckerK, SandersO, StevensT, WalkerZ (2019) Rate of cognitive decline in Alzheimer’s disease stratified by age. J Alzheimers Dis69, 1153–1160.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCR, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
37.
NasreddineZS, PhillipsNA, BédirianV, CharbonneauS, WhiteheadV, CollinI, CummingsJL, ChertkowH (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc53, 695–699.
38.
DelgadoC, AranedaA, BehrensMI (2017) Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years. Neurologia (Engl Ed)34, 376–385.
39.
JulayanontP, BrousseauM, ChertkowH, PhillipsN, NasreddineZS (2014) Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer’s disease. J Am Geriatr Soc62, 679–684.
40.
FirstMB (1997) Structured clinical interview for DSMIV axis I disorders: SCID-I/P, version 2.0. Biometrics Research Department, New York State Psychiatric Institute, New York.
41.
PowellMJD (2009) The BOBYQA algorithm for bound constrained optimization without derivatives. Cambridge NA Report NA2009/06, University of Cambridge.
42.
JohnsonPCD (2014) Extension of Nakagawa & Schielzeth’s to random slopes models. Methods Ecol Evol5, 944–946.
43.
NakagawaS, SchielzethH (2013) A general and simple method for obtaining2 from generalized linear mixed-effects models. Methods Ecol Evol4, 133–142.
44.
NakagawaS, JohnsonPCD, SchielzethH (2017) The coefficient of determination2 and intra-class correlation coefficient from generalized linear mixed-effects models revisited and expanded. J R Soc Interface14, 20170213.
45.
RubinDB (1974) Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol66, 688–701.
46.
FrankKA, MaroulisSJ, DuongMQ, KelceyBM (2013) What would it take to change an inference? Using Rubin’s causal model to interpret the robustness of causal inferences. Educ Eval Policy Anal35, 437–460.
47.
WhiteRS, LiptonRB, HallCB, SteinermanJR (2013) Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk. Neurology80, 1966–1972.
48.
LeiterU, EigentlerT, GarbeC (2014) Epidemiology of skin cancer. In Sunlight, Vitamin D and Skin Cancer, SpringerNew York, NY, pp. 120–140.
49.
WingoAP, DammerEB, BreenMS, LogsdonBA, DuongDM, TroncoscoJC, ThambisettyM, BeachTG, SerranoGE, ReimanEM, CaselliRJ, LahJJ, SeyfriedNT, LeveyAI, WingoTS (2019) Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age. Nat Commun10, 1619.
50.
AlmeidaOP, HankeyGJ, YeapBB, GolledgeJ, FlickerL (2017) Depression as a modifiable factor to decrease the risk of dementia. Transl Psychiatry7, e1117.
51.
TodaT, ParylakSL, LinkerSB, GageFH (2019) The role of adult hippocampal neurogenesis in brain health and disease. Mol Psychiatry24, 67–87.
52.
LangeM, JolyF, VardyJ, AhlesT, DuboisM, TronL, WinocurG, de RuiterMB, CastelH (2019) Cancer-related cognitive impairment: An update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol30, 1925–1940.
53.
RogersNK, RomeroC, SanMartínCD, PonceDP, SalechF, LópezMN, GleisnerA, TempioF, BehrensMI (2020) Inverse relationship between Alzheimer’s disease and cancer: How immune checkpoints might explain the mechanisms underlying age-related diseases. J Alzheimers Dis73, 443–454.
54.
SalechF, PonceDP, SanMartínCD, RogersNK, HenríquezM, BehrensMI (2018) Cancer imprints an increased PARP-1 and p53-dependent resistance to oxidative stress on lymphocytes of patients that later develop Alzheimer’s disease. Front Neurosci12, 58.
55.
BehrensMI, SilvaM, SalechF, PonceDP, MerinoD, SinningM, XiongC, RoeCM, QuestAFG (2012) Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer’s patients and skin cancer survivors: Increased apoptosis in Alzheimer’s and reduced necrosis in cancer. J Gerontol A Biol Sci Med Sci67, 1036–1040.
56.
PonceD, SalechF, MartinC, SilvaM, XiongC, RoeC, HenriquezM, QuestF, BehrensI (2014) Increased susceptibility to oxidative death of lymphocytes from Alzheimer patients correlates with dementia severity. Curr Alzheimer Res11, 892–898.
